COMMUNIQUÉS West-GlobeNewswire

-
PetMed Express D/B/A 1-800-PetMeds to Announce Its Fiscal Year End Financial Results on May 7, 2018
30/04/2018 -
T2 Biosystems Announces 2018 First Quarter Financial and Operational Results Release and Conference Call Date
30/04/2018 -
Inovio Pharmaceuticals to Report First Quarter 2018 Financial Results on May 9, 2018
30/04/2018 -
K2M Hosts the World’s Leading Spine Surgeons at Meeting of Minds™ 2018
30/04/2018 -
Chimerix to Announce First Quarter 2018 Financial Results on May 7, 2018
30/04/2018 -
Keryx Biopharmaceuticals Announces Changes to Management and Preliminary First Quarter 2018 Revenue
30/04/2018 -
Sirona Biochem to Exhibit at the Shanghai China Beauty Expo 2018
30/04/2018 -
International Endeavors Corporation, a Medical Marijuana IP Holdings Company today announces the introduction of OGGL, OFF-GRID GROW LAB
30/04/2018 -
Daré Bioscience announces funding award to further the development of Ovaprene™ from the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
30/04/2018 -
Orion has completed the sale of Orion Diagnostica business division
30/04/2018 -
Election of the Board of Directors on the annual general meeting
30/04/2018 -
Transactions under Novozymes’ stock buyback program
30/04/2018 -
Trading by management and close relations of management
30/04/2018 -
Changes to Biohit Oyj’s Management Team
30/04/2018 -
Curetis Announces Change of the Composition of Its Supervisory Board
30/04/2018 -
ABLYNX ANNOUNCES WARRANT EXERCISE
30/04/2018 -
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
30/04/2018 -
Sanofi: FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma
30/04/2018 -
Sanofi : FDA accorde un examen prioritaire au cemiplimab dans le traitement potentiel du carcinome épidermoïde cutané au stade avancé
30/04/2018
Pages